Please Note: This trial is no longer enrolling new participants
Phase I Study of Th-1 Dendritic Cell Immunotherapy in Combination with Standard Chemotherapy for the Adjuvant Treatment of Pancreatic Adenocarcinoma (DECIST)
| Protocol No. | CTO-H-42434 | Scope | National |
|---|---|---|---|
| Principal Investigator | Anita Turk | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase I |
